PatientsVille.com Logo


Pills Medical Research Studies

Up-to-date List of Pills Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Pills Medical Research Studies

Rank Status Study
1 Recruiting Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Condition: Oral Contraceptive
Interventions: Drug: Oral Contraceptive: Ortho-Novum® 1/35;   Drug: Oral Contraceptive: Ovcon® 35;   Drug: Oral Contraceptive: Microgestin Fe® 1/20
Outcome Measure: To measure breast cell proliferation levels between the three oral contraceptive dose groups.
2 Recruiting Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome
Condition: Adverse Effect of Oral Contraceptives, Sequela
Intervention: Drug: oc:E-E-desogestrel/vaginal ring:E-E -ethonogestrel
Outcome Measures: Change in Matsuda index during the oral contraceptive pill (E-E-desogestrel)/vaginal ring (E-E -ethonogestrel);   Change in high sensitive C-reactive protein (mg/l) during the oral contraceptive pill (E-E-desogestrel)/vaginal ring (E-E -ethonogestrel);   Change in Free Androgen Index during the oral contraceptive pill (E-E-desogestrel)/vaginal ring (E-E -ethonogestrel)
3 Recruiting Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
Conditions: Acute Coronary Syndrome;   Adverse Reaction to Antiplatelet Agent
Interventions: Drug: Ticagrelor mashed Pills;   Drug: Ticagrelor integral Pills
Outcome Measures: residual platelet reactivity;   high residual platelet reactivity;   Bleeding events;   Dyspnoea and/or symptomatic bradycardia
4 Recruiting Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure
Condition: Ischemic Heart Failure
Interventions: Drug: Qishen Yiqi Dripping Pills;   Drug: Qishen Yiqi dripping Pills dummy
Outcome Measures: 6MWT distance;   6MWT;   Composite endpoint;   Brain natriuretic peptide (BNP);   Echocardiography;   Cardiothoracic Ratio(CR);   Cardiac function classification, NYHA;   Minnesota life quality scale;   Scores from the four TCM diagnostic methods;   blood and urine routine tests,liver and renal function tests,serum electrolytes,electrocardiogram (ECG)
5 Unknown  A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
Condition: Prostate Cancer
Interventions: Dietary Supplement: Pomegranate pill;   Dietary Supplement: Pomegranate pill placebo
Outcome Measure: Pomegranate oxidative stress
6 Recruiting Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
Condition: Premenstrual Syndrome
Interventions: Drug: Yasmin;   Dietary Supplement: Calver;   Drug: Placebo
Outcome Measure: Improvement of premenstrual symptoms.
7 Unknown  Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial MMPs
Condition: Breakthrough Bleeding
Intervention: Drug: Doxycycline
Outcome Measures: Determine the effect of combined oral contraceptives on endometrial MMP expression.;   Determine the effect of sub-antimicrobial doxycycline on MMP expression and activity in continuous oral contraceptive users.
8 Recruiting Pharmacokinetics Study of Qing'E Pill
Condition: Menopause
Intervention: Drug: Qing'E pill
Outcome Measure: Pharmacokinetic parameters of the main components of Qing'E pill (Maximum plasma concentration (Cmax), Area under the plasma concentration curve (AUClast and AUC))
9 Recruiting Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
Conditions: Coronary Heart Disease;   Essential Hypertension
Intervention: Drug: danshen dripping pill
Outcome Measures: Pulse wave velocity;   ankle-brachial index
10 Recruiting Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
Condition: Ischemic Stroke
Intervention: Drug: Huatuo Zaizao Pills
Outcome Measures: modified Rankin Scale;   modified Rankin Scale,NIHSS, Barthel Index, and MMSE
11 Unknown  Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents
Condition: Contraception
Interventions: Drug: Desogestrel-Ethinyl Estradiol 21 tablets;   Drug: Desogestrel-Ethinyl Estradiol 28 tablets
Outcome Measures: The primary objective is to compare the compliance rates of adolescents who take OCPs continuously to those who take OCPs cyclically.;   The number of girls who have positive pregnancy test results at 12 months
12 Unknown  Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris
Condition: Stable Angina Pectoris
Interventions: Drug: Total Flavonoids of Propolis dropping pill;   Drug: total Flavonoids of Propolis dropping pill
Outcome Measures: Improvement of total exercise time of treadmill exercise test;   The marked effective rate of angina pectoris;   Attack times of angina pectoris;   Pain degree of angina pectoris;   Duration of angina pectoris attack;   Dose change of nitroglycerin;   The main symptoms of Chinese Traditional Medicine;   Score change of the Seattle Angina Questionnaire (SAQ);   Improvement of ECG;   Improvement of other indexes of treadmill exercise test;   Time to ST-segment deviation>1mm and positive symptoms appear
13 Recruiting A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy
Condition: Cervical Radiculopathy
Intervention: Drug: Qishe Pill
Outcome Measures: pain severity(measured with a visual analogue scale, VAS);   SF-36;   Neck Disability Index(NDI);   Kidney function test;   Liver function test;   ECG;   Occult Blood;   Urine routine;   Blood routine;   Number of participants with Concomitant medication;   Number of participants with Adverse Events
14 Unknown  Qishe Pill for Cervical Radiculopathy
Condition: Cervical Radiculopathy
Interventions: Drug: Qishe Pill;   Drug: Qishe Placebo
Outcome Measures: Neck Disability Index;   SF 36;   satisfaction;   Sick leave;   Alt;   Visual Analogue Scale;   BUN;   Cr;   Bun;   Br
15 Recruiting Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery
Conditions: Bariatric Surgery Candidate;   Contraception
Intervention: Drug: ethinyl estradiol-levonorgestrel
Outcome Measures: Serum hormone levels of Ethinyl estradiol and levonorgestrel, as assessed by area under the curve (AUC);   Endometrial thickness on transvaginal ultrasound;   Serum levels of FSH, LH, E and P;   Cervical mucus score;   Presence of ovarian follicles on transvaginal ultrasound
16 Not yet recruiting Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Condition: Bladder Cancer
Interventions: Drug: Genistein;   Drug: Sugar pill
Outcome Measures: Change in severity of urinary symptoms as determined by the IPSS questionnaire score.;   Rate of cancer recurrence determined at 10-week biopsy.
17 Recruiting Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Drug: pomegranate-extract pill;   Other: placebo;   Other: laboratory biomarker analysis;   Other: pharmacological study
Outcome Measures: Change in plasma IGF-1;   Compliance, in terms of the number of Pills missed;   Incidence of adverse events graded per Common Terminology Criteria for Adverse Events (CTCAE);   Change in plasma biomarker levels;   Total serum PSA;   Change in tissue biomarker levels;   Change in levels of PFD constituents/metabolites;   Change in Gleason grade;   Change in tumor volume on prostate biopsy
18 Recruiting HSG and Tubal Patency Study
Condition: Tubal Patency
Interventions: Drug: combined oral contraceptive;   Drug: DepoProvera
Outcome Measure: if menstrual cycle stage or hormonal treatment of women affect functional tubal patency as assessed by HSG
19 Recruiting Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Conditions: Insulin Sensitivity;   Cardiovascular Risk;   Perimenopausal Disorder
Intervention: Drug: Ortho Cyclen®
Outcome Measures: Change from Baseline in Estrogen Metabolites at 6 months;   Change from Baseline in Insulin Sensitivity at 6 months;   Change from Baseline in Flow-mediated Vasodilatation at 6 months;   Change from Baseline in Carotid Intima Media Thickness at 6 months;   Change from Baseline in Urinary Estrogen Metabolites at 6 months;   Change from Baseline in Acute Insulin Response to Glucose at 6 months;   Change from Baseline in Glucose Effectiveness in 6 months;   Change from Baseline in Disposition Index at 6 months;   Change from Baseline in Fasting Insulin at 6 months;   Change from Baseline in Fasting Glucose at 6 months;   Change from Baseline in Areas-under-the-curve for Insulin at 6 months;   Change from Baseline in Areas-under-the-curve for Glucose at 6 months;   Change from Baseline in Cardiovascular Markers (hsCRP, MCP-1, ICAM-1, V-CAM-1, PAI-1, tPA, RBP4, adiponectin, MMP, MPO) at 6 months;   Change from Baseline in Blood Pressure at 6 months;   Change from Baseline in Fasting Lipid Panel at 6 months;   Change from Baseline in Body Mass Index in 6 months;   Change from Baseline in Waist-to-hip Ratio at 6 months;   Hemoglobin A1c;   Serum free fatty acids
20 Recruiting Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
Conditions: Polycystic Ovarian Syndrome;   Hyperandrogenism;   Menstrual Irregularities
Interventions: Drug: 20 mcg ethinylestradiol /3 mg drospirenone;   Drug: 20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
Outcome Measures: Change from Baseline in Activated recalcification time;   Change from Baseline in Activated partial thromboplastin time;   Change from Baseline in Prothrombin time;   Change from Baseline in International normalized ratio;   Change from Baseline in D-dimer concentration;   Change from Baseline in Fibrinogen concentration;   Change from Baseline in Soluble fibrin-monomer complexes concentration;   Change from Baseline in Platelet aggregation;   Change from Baseline in Antithrombin III activity;   Change from Baseline in Reserve plasminogen index;   Change from Baseline in Erythrocyte Lipoperoxidation products, extractable in heptane and isopropanol;   Change from Baseline in Malondialdehyde Concentration in Erythrocytes;   Change from Baseline in Glutathion-S-transferase Activity in Erythrocytes;   Change from Baseline in Superoxide dismutase Activity in Erythrocytes;   Vitamin A and E plasma concentration;   Frequency of adverse effects;   Subjective tolerability of contraceptives

These studies may lead to new treatments and are adding insight into Pills etiology and treatment.

A major focus of Pills research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Pills